Search research articles
Contact Us
Filters
Showing results (81-90 of 224) with videos related to
Page
of 23
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 20, 2024
MAFLD predicts cardiovascular disease risk better than MASLD
Ziyan Pan, Gamal Shiha, Gamal Esmat, et al.
Journal of Gastroenterology and Hepatology
|
November 30, 2025
Lean MASH: A High-Risk Subtype With Significant Cardiometabolic Burden
Yasser Fouad, Alaa M Mostafa, Ahmed Gomaa, et al.
Journal of Clinical and Experimental Hepatology
|
March 25, 2024
Post-Liver Transplant Metabolic Syndrome
Ashok Choudhury, Satender P Singh, Akhil Desmukh, et al.
Frontiers in Immunology
|
April 9, 2021
Hepatic Dendritic Cells in the Development and Progression of Metabolic Steatohepatitis
Nahum Méndez-Sánchez, Jacqueline Córdova-Gallardo, Beatriz Barranco-Fragoso, et al.
The Lancet. Gastroenterology & Hepatology
|
March 14, 2026
The evolving clinical trial landscape in the MENA region
Yasser Fouad, Abdulla Al Hassani, Nawal Alkhalidi, et al.
Hepatology International
|
January 16, 2022
Predictive performance and clinical utility of HCC risk scores in chronic hepatitis C: a comparative study
Gamal Shiha, Nabiel N H Mikhail, Reham Soliman, et al.
Therapeutic Advances in Endocrinology and Metabolism
|
December 29, 2025
GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications
Mariana M Ramírez-Mejía, Guadalupe Ponciano-Rodriguez, Mohammed Eslam, et al.
Nature Reviews. Gastroenterology & Hepatology
|
February 23, 2026
Hepatitis C elimination: is it time to redefine the goals?
Yasser Fouad, Ming-Lung Yu, Saeed Hamid, et al.
Clinical and Molecular Hepatology
|
November 10, 2021
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, et al.
Hepatobiliary Surgery and Nutrition
|
February 12, 2026
What is new in the 2025 APASL guidelines for metabolic dysfunction-associated fatty liver disease?
Ziyan Pan, Necati Örmeci, Jinjun Chen, et al.
Page
of 23
Search research articles
Search
Showing results (81-90 of 224) with videos related to
Sort By:
Page
of 23
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 20, 2024
MAFLD predicts cardiovascular disease risk better than MASLD
Ziyan Pan, Gamal Shiha, Gamal Esmat, et al.
Journal of Gastroenterology and Hepatology
|
November 30, 2025
Lean MASH: A High-Risk Subtype With Significant Cardiometabolic Burden
Yasser Fouad, Alaa M Mostafa, Ahmed Gomaa, et al.
Journal of Clinical and Experimental Hepatology
|
March 25, 2024
Post-Liver Transplant Metabolic Syndrome
Ashok Choudhury, Satender P Singh, Akhil Desmukh, et al.
Frontiers in Immunology
|
April 9, 2021
Hepatic Dendritic Cells in the Development and Progression of Metabolic Steatohepatitis
Nahum Méndez-Sánchez, Jacqueline Córdova-Gallardo, Beatriz Barranco-Fragoso, et al.
The Lancet. Gastroenterology & Hepatology
|
March 14, 2026
The evolving clinical trial landscape in the MENA region
Yasser Fouad, Abdulla Al Hassani, Nawal Alkhalidi, et al.
Hepatology International
|
January 16, 2022
Predictive performance and clinical utility of HCC risk scores in chronic hepatitis C: a comparative study
Gamal Shiha, Nabiel N H Mikhail, Reham Soliman, et al.
Therapeutic Advances in Endocrinology and Metabolism
|
December 29, 2025
GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications
Mariana M Ramírez-Mejía, Guadalupe Ponciano-Rodriguez, Mohammed Eslam, et al.
Nature Reviews. Gastroenterology & Hepatology
|
February 23, 2026
Hepatitis C elimination: is it time to redefine the goals?
Yasser Fouad, Ming-Lung Yu, Saeed Hamid, et al.
Clinical and Molecular Hepatology
|
November 10, 2021
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, et al.
Hepatobiliary Surgery and Nutrition
|
February 12, 2026
What is new in the 2025 APASL guidelines for metabolic dysfunction-associated fatty liver disease?
Ziyan Pan, Necati Örmeci, Jinjun Chen, et al.
Page
of 23